Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Dupain, C."'
Autor:
Moreira, A., Poulet, A., Masliah-Planchon, J., Lecerf, C., Vacher, S., Larbi Chérif, L., Dupain, C., Marret, G., Girard, E., Syx, L., Hoffmann, C., Jeannot, E., Klijanienko, J., Guillou, I., Mariani, O., Dubray-Vautrin, A., Badois, N., Lesnik, M., Choussy, O., Calugaru, V., Borcoman, E., Baulande, S., Legoix, P., Albaud, B., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.
Publikováno v:
In ESMO Open August 2021 6(4)
Autor:
de Guillebon, E., Jimenez, M., Mazzarella, L., Betsou, F., Stadler, P., Peták, I., Jeannot, E., Chanas, L., Servant, N., Marret, G., Duso, B.A., Legrand, F., Kornerup, K.N., Bernhart, S.H., Balogh, G., Dóczi, R., Filotás, P., Curigliano, G., Bièche, I., Guérin, J., Dirner, A., Neuzillet, C., Girard, N., Borcoman, E., Larbi Chérif, L., Tresca, P., Roufai, D.B., Dupain, C., Scholl, S., André, F., Fernandez, X., Filleron, T., Kamal, M., Le Tourneau, C.
Publikováno v:
In ESMO Open June 2021 6(3)
Autor:
Kamal, Maud, Lameiras, Sonia, Deloger, Marc, Morel, Adeline, Vacher, Sophie, Lecerf, Charlotte, Dupain, C. lia, Jeannot, Emmanuelle, Girard, Elodie, Baulande, Sylvain, Dubot, Coraline, Kenter, Gemma, Jordanova, Ekaterina S., Berns, Els M. J. J., Bataillon, Guillaume, Popovic, Marina, Rouzier, Roman, Cacheux, Wulfran, le Tourneau, Christophe, Nicolas, Alain, Servant, Nicolas, Scholl, Suzy M., Bièche, Ivan, de la Rochefordiere, Anne, Fumoleau, Pierre, Mandic, Aljosa, Samet, Nina, Kamoun, Choumouss, Rondoff, Windy, Armanet, Sebastien, Rohel, Alexandra, Neffati, Souhir, Legrier, Marie-Emmanuelle, Mabiala, Sinette Ngoumou, Dureau, Sylvain, Errera, Coralie, Craina, Marius, Margan, Madalin, Samuels, Sanne, Zijlmans, Henry, Hillemanns, Peter, Dema, Sorin, Dema, Alis, Malenkovic, Goran, Djuran, Branislav, Floquet, Anne, Guyon, Frédéric, Colombo, Pierre Emmanuel, Fabbro, Michel, Kerr, Christine
Publikováno v:
British Journal of Cancer, 124(4), 777-785. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2021, 124 (4), pp.777-785. ⟨10.1038/s41416-020-01153-4⟩
British Journal of Cancer, Cancer Research UK, 2020, 124 (4), pp.777-785. ⟨10.1038/s41416-020-01153-4⟩
British journal of cancer, 124(4), 777-785. Nature Publishing Group
RAIDs Consortium 2021, ' Human papilloma virus (HPV) integration signature in Cervical Cancer : identification of MACROD2 gene as HPV hot spot integration site ', British Journal of Cancer, vol. 124, no. 4, pp. 777-785 . https://doi.org/10.1038/s41416-020-01153-4
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2021, 124 (4), pp.777-785. ⟨10.1038/s41416-020-01153-4⟩
British Journal of Cancer, Cancer Research UK, 2020, 124 (4), pp.777-785. ⟨10.1038/s41416-020-01153-4⟩
British journal of cancer, 124(4), 777-785. Nature Publishing Group
RAIDs Consortium 2021, ' Human papilloma virus (HPV) integration signature in Cervical Cancer : identification of MACROD2 gene as HPV hot spot integration site ', British Journal of Cancer, vol. 124, no. 4, pp. 777-785 . https://doi.org/10.1038/s41416-020-01153-4
Background Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the most important risk factor. We analysed the association between different viral integration sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d535c72d6efa3c4ba73a9be665c15bb
https://pure.eur.nl/en/publications/5693bcdc-8fe3-4b72-ac1a-f69be866da78
https://pure.eur.nl/en/publications/5693bcdc-8fe3-4b72-ac1a-f69be866da78
Autor:
Le Tourneau, C., Ghiringhelli, F., Saada, E.B., Chaltiel, R., Vansteene, D., Durando, X., You, B., Borel, C., Bigot, F., Abdeddaim, C., Marret, G., Jeannot, E., Guerini Rocco, E., Frige, G., Servant, N., Dupain, C., Kamal, M., Legrand, F., Jimenez, M., Filleron, T.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S583-S583
Autor:
Coutzac, C., Bigot, F., Vansteene, D., Dos Santos, M., Ghiringhelli, F., You, B., Lambert, A., Gomez-Roca, C.A., Abdeddaim, C., Neuzillet, C., Jeannot, E., Guerini Rocco, E., Frige, G., Mazzarella, L., Dupain, C., Kamal, M., Legrand, F., Jimenez, M., Filleron, T., Le Tourneau, C.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S415-S415
Autor:
Hescot, S., Marret, G., Hadoux, J., Durand, A., Jannin, A., Laboureau, S., Haissaguerre, M., Perrier, M., Lepage, C., Guimbaud, R., Lamy, C., Dupain, C., Do Cao, C., Robelin, P., Baudin, E.
Publikováno v:
Annales d'Endocrinologie; October 2024, Vol. 85 Issue: 5 p367-367, 1p
Autor:
Dupain, C., Gutman, T., Girard, E., du Rusquec, P., Sablin, M-P., Tresca, P., Neuzillet, C., Vincent-Salomon, A., Antonio, S., Franck, C., Galut, M., Allory, Y., Cyrta, J., Guillou, I., Wong, J., Le Tourneau, C., Bièche, I., Servant, N., Kamal, M., Masliah-Planchon, J.
Publikováno v:
In Annals of Oncology September 2021 32 Supplement 5:S388-S388
Publikováno v:
In ESMO Open 30 June-3 July 2018 3 Supplement 2:A221-A221
Autor:
Loriot Y; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; PRISM, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France. maud.kamal@gustaveroussy.fr., Syx L; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Nicolle R; Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-, 75018, Paris, France., Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Menssouri N; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Duquesne I; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Lavaud P; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Nicotra C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Ngocamus M; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Lacroix L; Biopath department, Gustave Roussy, Villejuif, France., Tselikas L; Department of interventional radiology, Gustave Roussy, Villejuif, France., Crehange G; Department of Radiothérapie, Institut Curie, 75005 Paris & 92210 Saint-Cloud, Paris, France., Friboulet L; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France., Castel-Ajgal Z; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Neuzillet Y; Department of Urology, Foch Hospital, Suresnes, France., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Beuzeboc P; Department of Urology, Foch Hospital, Suresnes, France., Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Gutman T; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Wong J; Department of Genetics, Institut Curie, 75005, Paris, France., Radvanyi F; UMR144, Institut Curie, 75005, Paris, France., Dureau S; Biometry unit, direction of clinical research, Institut Curie, 75005, Paris, France., Scoazec JY; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Biopath department, Gustave Roussy, Villejuif, France., Servant N; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Allory Y; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France., Besse B; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Andre F; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Massard C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Bieche I; Department of Genetics, Institut Curie, 75005, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université Paris Cité, Paris, France.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 30; Vol. 15 (1), pp. 9370. Date of Electronic Publication: 2024 Oct 30.
Autor:
Lebedeva A; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia. lebedeva@oncoatlas.ru.; Laboratory of Applied Genomic Technologies, Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia. lebedeva@oncoatlas.ru., Belova E; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia.; Laboratory of Applied Genomic Technologies, Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Kavun A; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia., Taraskina A; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia., Bartoletti M; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Bièche I; Department of Genetics, Institut Curie, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université Paris Cité, Paris, France., Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Rios-Hoyo A; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Institut Hospitalo Universitaire PRISM, National PRecISion Medicine Center in Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Luchini C; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy., Poyarkov S; Sistema BioTech, Moscow, Russia., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research unit, Institut Curie, Saint-Cloud, France.; Faculty of Medicine, Paris-Saclay University, Paris, France., Veselovsky E; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia., Mileyko V; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia.; Laboratory of Applied Genomic Technologies, Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia., Ivanov M; OncoAtlas LLC, Leninsky Ave, 1/4A, Moscow, 119049, Russia.; Laboratory of Applied Genomic Technologies, Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia.
Publikováno v:
Molecular diagnosis & therapy [Mol Diagn Ther] 2024 Oct 05. Date of Electronic Publication: 2024 Oct 05.